La Jolla Pharmaceutical Company (LJPC): Price and Financial Metrics

LJPC POWR Grades

• Quality is the dimension where LJPC ranks best; there it ranks ahead of 98.32% of US stocks.
• LJPC's strongest trending metric is Stability; it's been moving up over the last 179 days.
• LJPC ranks lowest in Momentum; there it ranks in the 12th percentile.

LJPC Stock Summary

• La Jolla Pharmaceutical Co's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 3.95% of US listed stocks.
• LJPC's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 4.61% of US stocks.
• With a year-over-year growth in debt of 393.1%, La Jolla Pharmaceutical Co's debt growth rate surpasses 96.69% of about US stocks.
• Stocks that are quantitatively similar to LJPC, based on their financial statements, market capitalization, and price volatility, are PUBM, OMCL, UPST, EQX, and HEAR.
• Visit LJPC's SEC page to see the company's official filings. To visit the company's web site, go to lajollapharmaceutical.com.

LJPC Valuation Summary

• LJPC's price/sales ratio is 1.6; this is 85.9% lower than that of the median Healthcare stock.
• LJPC's price/sales ratio has moved NA NA over the prior 115 months.
• LJPC's price/earnings ratio has moved up 39.7 over the prior 115 months.

Below are key valuation metrics over time for LJPC.

LJPC Growth Metrics

The 2 year net cashflow from operations growth rate now stands at 40.59%.
• Its 4 year net income to common stockholders growth rate is now at -88.95%.
• The 4 year net cashflow from operations growth rate now stands at -97.43%.

Over the past 34 months, LJPC's revenue has gone up $62,078,000.

The table below shows LJPC's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	75.72	28.244	19.66
2021-09-30	74.461	17.798	12.413
2021-06-30	70.219	7.269	2.913
2021-03-31	59.965	-8.213	-16.412
2020-12-31	33.419	-37.64	-39.421
2020-09-30	29.718	-47.49	-61.176

LJPC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• LJPC has a Quality Grade of B, ranking ahead of 86.96% of graded US stocks.
• LJPC's asset turnover comes in at 0.82 -- ranking 32nd of 680 Pharmaceutical Products stocks.
• BTX, ITCI, and LFVN are the stocks whose asset turnover ratios are most correlated with LJPC.

The table below shows LJPC's key quality metrics over time.